首页 产品中心 抗体 生化试剂 研究领域
服务与支持 定制服务 技术支持 促销活动 关于我们
登 录 注 册

p300 Rabbit mAb  (货号:AAY1850)

A
小A 扫码咨询
宿主: Rabbit克隆性: Monoclonal反应: Human,Mouse,RatWBIFIPELISA
货号 AAY1850
靶点/基因 EP300/Histone acetyltransferase p300
宿主 Rabbit
克隆性 Monoclonal
反应种属 Human, Mouse, Rat
应用 WB, IF, IP, ELISA

货号:AAY1850

规格价格
50ul ¥1150.00 加购物车
100ul ¥2100.00 加购物车
  • 产品信息

  • 应用指南

  • 相关产品

  • 抗原信息

  • 靶点信息

  • 资料与支持

  • 实验步骤

  • 常见问题

反应 Human,Mouse,Rat
宿主 Rabbit
克隆性 Monoclonal
克隆号 AA1071R
同种型 IgG,Kappa
应用 WBIFIPELISA
推荐浓度 WB: 1:2000-1:10000
IF: 1:200-1:1000
ELISA: 1:5000-1:20000
IP: 1:50-1:200
理论分子量 264kD
实测分子量 300kD
形式 Liquid
保存条件 Store at -20℃. Avoid freeze / thaw cycles.
Buffer: PBS with 0.75% BSA,50% glycerol,pH7.852.
偶联物 Unconjugated
阳性对照
细胞定位 Cytoplasm, Nucleus, Chromosome
纯化 亲和纯化

应用与推荐条件

快速判断怎么用

以下条件基于推荐浓度、验证图说明与通用实验要求整理,可作为预实验起点;不同样本和检测体系建议做梯度优化。

WB WB 推荐条件
推荐稀释 1:2000-1:10000
建议样本/阳性对照 建议选择靶点高表达样本作为阳性对照
关键条件 建议使用新鲜裂解样本,按推荐稀释比例孵育一抗,并关注理论/实测分子量
预期结果 预期信号/条带约 300kD
对照设置 建议设置阳性样本、阴性样本和二抗/同型对照
IF IF 推荐条件
推荐稀释 1:200-1:1000
建议样本/阳性对照 建议选择靶点高表达样本作为阳性对照
关键条件 建议优化固定、通透和封闭条件,并设置二抗空白对照
预期结果 预期荧光定位:Cytoplasm, Nucleus, Chromosome
对照设置 建议设置阳性样本、阴性样本和二抗/同型对照
IP IP 推荐条件
推荐稀释 1:50-1:200
建议样本/阳性对照 建议选择靶点高表达样本作为阳性对照
关键条件 建议从页面推荐浓度开始,结合样本与检测体系做梯度优化
预期结果 预期信号/条带约 300kD
对照设置 建议设置阳性样本、阴性样本和二抗/同型对照
ELISA ELISA 推荐条件
推荐稀释 1:5000-1:20000
建议样本/阳性对照 建议选择靶点高表达样本作为阳性对照
关键条件 建议从页面推荐浓度开始,结合样本与检测体系做梯度优化
预期结果 预期信号/条带约 300kD
对照设置 建议设置阳性样本、阴性样本和二抗/同型对照

相关产品

查找相关产品 >>

抗原信息

抗原信息 请咨询 技术支持
序列 Email For Sequence

靶点信息

研究背景 Functions as a histone acetyltransferase and regulates transcription via chromatin remodeling (PubMed:23415232, PubMed:23934153, PubMed:40240600, PubMed:8945521). Acetylates all four core histones in nucleosomes (PubMed:23415232, PubMed:23934153, PubMed:8945521). Histone acetylation gives an epigenetic tag for transcriptional activation (PubMed:23415232, PubMed:23934153, PubMed:8945521). Mediates acetylation of histone H3 at 'Lys-122' (H3K122ac), a modification that localizes at the surface of the histone octamer and stimulates transcription, possibly by promoting nucleosome instability (PubMed:23415232). Mediates acetylation of histone H3 at 'Lys-18' and 'Lys-27' (H3K18ac and H3K27ac, respectively) (PubMed:21131905, PubMed:23911289). Also able to acetylate histone lysine residues that are already monomethylated on the same side chain to form N6-acetyl-N6-methyllysine (Kacme), an epigenetic mark of active chromatin associated with increased transcriptional initiation (PubMed:37731000). Catalyzes formation of histone H4 acetyl-methylated at 'Lys-5' and 'Lys-12' (H4K5acme and H4K12acme, respectively) (PubMed:37731000). In response to DNA damage, catalyzes acetylation of histone H1 at 'Lys-75' (H1K75ac) following histone H1 deamidation by CTPS1, increasing chromatin accessibility to facilitate the recruitment of DNA repair proteins (PubMed:40240600). Also functions as acetyltransferase for non-histone targets, such as ALX1, HDAC1, PRDM16, PRMT1, SIRT2, STAT3, ZNF76 or GLUL (PubMed:12929931, PubMed:15653507, PubMed:16285960, PubMed:16337145, PubMed:16762839, PubMed:18722353, PubMed:18782771, PubMed:26990986). Acetylates 'Lys-131' of ALX1 and acts as its coactivator (PubMed:12929931). Acetylates SIRT2 and is proposed to indirectly increase the transcriptional activity of p53/TP53 through acetylation and subsequent attenuation of SIRT2 deacetylase function (PubMed:18722353). Following DNA damage, forms a stress-responsive p53/TP53 coactivator complex with JMY which mediates p53/TP53 acetylation, thereby increasing p53/TP53-dependent transcription and apoptosis (PubMed:11511361, PubMed:15448695). Promotes chromatin acetylation in heat shock responsive HSP genes during the heat shock response (HSR), thereby stimulating HSR transcription (PubMed:18451878). Acetylates HDAC1 leading to its inactivation and modulation of transcription (PubMed:16762839). Acetylates 'Lys-247' of EGR2 (By similarity). Acts as a TFAP2A-mediated transcriptional coactivator in presence of CITED2 (PubMed:12586840). Plays a role as a coactivator of NEUROD1-dependent transcription of the secretin and p21 genes and controls terminal differentiation of cells in the intestinal epithelium. Promotes cardiac myocyte enlargement (PubMed:14752053). Can also mediate transcriptional repression. Acetylates FOXO1 and enhances its transcriptional activity (PubMed:15890677). Acetylates STAT3 at different sites, promoting both STAT3 dimerization and activation and recruitment to chromatin (PubMed:15653507, PubMed:16285960, PubMed:18782771). Acetylates BCL6 which disrupts its ability to recruit histone deacetylases and hinders its transcriptional repressor activity (PubMed:12402037). Participates in CLOCK or NPAS2-regulated rhythmic gene transcription; exhibits a circadian association with CLOCK or NPAS2, correlating with increase in PER1/2 mRNA and histone H3 acetylation on the PER1/2 promoter (PubMed:14645221). Acetylates MTA1 at 'Lys-626' which is essential for its transcriptional coactivator activity (PubMed:16617102). Acetylates XBP1 isoform 2; acetylation increases protein stability of XBP1 isoform 2 and enhances its transcriptional activity (PubMed:20955178). Acetylates PCNA; acetylation promotes removal of chromatin-bound PCNA and its degradation during nucleotide excision repair (NER) (PubMed:24939902). Acetylates MEF2D (PubMed:21030595). Acetylates and stabilizes ZBTB7B protein by antagonizing ubiquitin conjugation and degradation, this mechanism may be involved in CD4/CD8 lineage differentiation (PubMed:20810990). Acetylates GABPB1, impairing GABPB1 heterotetramerization and activity (By similarity). Acetylates PCK1 and promotes PCK1 anaplerotic activity (PubMed:30193097). Acetylates RXRA and RXRG (PubMed:17761950). Acetylates isoform M2 of PKM (PKM2), promoting its homodimerization and conversion into a protein kinase (PubMed:24120661). Acetylates RPTOR in response to leucine, leading to activation of the mTORC1 complex (PubMed:30197302, PubMed:32561715). Acetylates RICTOR, leading to activation of the mTORC2 complex (PubMed:22084251). Mediates cAMP-gene regulation by binding specifically to phosphorylated CREBBP (PubMed:8917528). In addition to protein acetyltransferase, can use different acyl-CoA substrates, such as (2E)-butenoyl-CoA (crotonyl-CoA), butanoyl-CoA (butyryl-CoA), 2-hydroxyisobutanoyl-CoA (2-hydroxyisobutyryl-CoA), lactoyl-CoA, propanoyl-CoA (propionyl-CoA) or isonicotinyl-CoA, and is able to mediate protein crotonylation, butyrylation, 2-hydroxyisobutyrylation, lactylation, propionylation or isonicotinylation, respectively (PubMed:17267393, PubMed:25818647, PubMed:29775581, PubMed:31645732, PubMed:34545082). Acts as a histone crotonyltransferase; crotonylation marks active promoters and enhancers and confers resistance to transcriptional repressors (PubMed:25818647). Histone crotonyltransferase activity is dependent on the concentration of (2E)-butenoyl-CoA (crotonyl-CoA) substrate and such activity is weak when (2E)-butenoyl-CoA (crotonyl-CoA) concentration is low (PubMed:25818647). Also acts as a histone butyryltransferase; butyrylation marks active promoters (PubMed:17267393). Catalyzes histone lactylation in macrophages by using lactoyl-CoA directly derived from endogenous or exogenous lactate, leading to stimulates gene transcription (PubMed:31645732). Acts as a protein-lysine 2-hydroxyisobutyryltransferase; regulates glycolysis by mediating 2-hydroxyisobutyrylation of glycolytic enzymes (PubMed:29775581). Functions as a transcriptional coactivator for SMAD4 in the TGF-beta signaling pathway (PubMed:25514493)
基因 ID 2033
基因名 EP300;Histone acetyltransferase p300;EP300;P300;Histone acetyltransferase p300;p300 HAT;E1A-associated protein p300
Swiss Q09472
别名 EP300;Histone acetyltransferase p300;EP300;P300;Histone acetyltransferase p300;p300 HAT;E1A-associated protein p300

资料与技术支持

验证数据

欢迎联系技术支持获取验证图与应用案例。

文献引用

暂无公开文献关联,欢迎联系技术支持获取更多应用案例。

咨询案例
客户评价

暂无客户评价,使用后可提交评价与实验图片。

提交反馈
技术支持

可协助确认应用、样本、稀释比例、阳性/阴性对照和实验条件。

进入支持中心
需要确认应用条件?

请提供货号 AAY1850、实验应用、样本类型和检测体系,技术支持可协助确认稀释比例、阳性/阴性对照和 COA/批次资料。

常见问题

当前页面标注应用包括 WB, IF, IP, ELISA,建议结合页面验证图和推荐稀释比例进行预实验优化。
可通过页面询价/留言入口提交货号和批号,技术支持会协助提供对应批次资料。
页面推荐条件可作为起始浓度,不同样本、固定方式和检测体系可能需要梯度优化。

实验步骤

实验步骤
AAY1850